Minerva Neurosciences President resigns; James O'Connor named Chief Business Officer and General Counsel

Minerva Neurosciences, Inc.

Geoffrey Race resigned as President effective March 31, 2026 after 16 years with the company.
Race will serve as consultant from April 15, 2026 to April 14, 2027 at £333/hour (min 35 hrs/month).
James O'Connor appointed Chief Business Officer and General Counsel effective April 21, 2026.
Press release highlights focus on roluperidone for negative symptoms of schizophrenia and planned Phase 3 trial.
Race receives full vesting of outstanding stock options with exercise period extended to January 1, 2030.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.